What is the dosage and treatment plan for Valacyclovir (valacyclovir) for herpes simplex virus infections?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Valacyclovir Dosage and Treatment Plan for Herpes Simplex Virus Infections

For herpes simplex virus infections, valacyclovir should be dosed as follows: 2 grams twice daily for 1 day for cold sores, 1 gram twice daily for 10 days for initial genital herpes episodes, and 500 mg twice daily for 3 days for recurrent genital herpes episodes. 1

Dosing Recommendations by HSV Infection Type

Cold Sores (Herpes Labialis)

  • Adults and children ≥12 years: 2 grams twice daily for 1 day (12 hours apart) 1
  • Initiate at earliest symptom (tingling, itching, burning)
  • Do not exceed 1 day of treatment

Genital Herpes

Initial Episode

  • Recommended dose: 1 gram twice daily for 10 days 1
  • Most effective when started within 48 hours of symptom onset

Recurrent Episodes

  • Recommended dose: 500 mg twice daily for 3 days 1
  • Initiate at first sign or symptom of an episode

Suppressive Therapy

  • Normal immune function: 1 gram once daily 1
  • Alternative for ≤9 recurrences/year: 500 mg once daily 1
  • HIV-infected patients (CD4+ ≥100 cells/mm³): 500 mg twice daily 1

Reduction of Transmission

  • For source partner with ≤9 recurrences/year: 500 mg once daily 1

Dosage Adjustments for Special Populations

Renal Impairment

Dosage adjustment is necessary based on creatinine clearance 1:

Indication Normal Dosage CrCl 30-49 mL/min CrCl 10-29 mL/min CrCl <10 mL/min
Cold sores 2g twice daily for 1 day No reduction 1g every 24 hours 500mg every 24 hours
Genital herpes (recurrent) 500mg every 12 hours No reduction 500mg every 24 hours 500mg every 24 hours
Genital herpes (suppressive) 1g every 24 hours No reduction 500mg every 24 hours 500mg every 24 hours
Suppressive (≤9 recurrences/year) 500mg every 24 hours No reduction 500mg every 48 hours 500mg every 48 hours
HIV-infected patients 500mg every 12 hours No reduction 500mg every 24 hours 500mg every 24 hours

Hemodialysis Patients

  • Administer recommended dose after hemodialysis 1
  • Approximately one-third of acyclovir is removed during a 4-hour hemodialysis session

Clinical Efficacy

Valacyclovir has demonstrated effectiveness in multiple clinical scenarios:

  • Cold sores: Reduces duration when initiated at earliest symptoms 1
  • Initial genital herpes: As effective as acyclovir (200 mg 5 times daily) with more convenient dosing 2
  • Recurrent genital herpes: Reduces duration of viral shedding, hastens lesion healing, and decreases lesion-associated pain 3
  • Suppressive therapy: Significantly prolongs time to recurrent episodes compared with placebo 4
  • Transmission reduction: Reduces risk of HSV-2 transmission by 75% for symptomatic acquisition and 48% for overall acquisition 1

Advantages Over Acyclovir

Valacyclovir offers significant advantages over acyclovir:

  • Better oral bioavailability (3-5 times higher acyclovir exposure) 5, 3
  • Less frequent dosing (twice daily vs. five times daily) 2
  • Comparable efficacy and safety profile 6
  • Improved compliance due to simplified regimen 2

Important Clinical Considerations

  • Initiate treatment at earliest signs/symptoms for optimal efficacy 1
  • May be taken without regard to meals 1
  • For patients unable to swallow tablets, an oral suspension can be prepared extemporaneously 1
  • Monitor renal function in patients with known renal impairment 1
  • Well tolerated with a safety profile similar to acyclovir or placebo 3

Valacyclovir represents an advance in antiherpes therapy with its convenient dosing regimen and established efficacy, making it an excellent first-line treatment option for herpes simplex virus infections.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.